NCT03959514View on ClinicalTrials.gov

AT247, NovoRapid® and Fiasp® in Glucose Clamp Study

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 12, 2019

Primary Completion Date

July 30, 2019

Study Completion Date

August 8, 2019

Conditions
Diabetes Mellitus, Type 1
Interventions
BIOLOGICAL

NovoRapid

Rapid acting prandial insulin aspart

BIOLOGICAL

Fiasp

Fast acting prandial insulin aspart

BIOLOGICAL

AT247

Ultra rapid acting prandial insulin aspart

Trial Locations (1)

8010

Clinical Research Centre, Graz

All Listed Sponsors
lead

Arecor Limited

INDUSTRY

NCT03959514 - AT247, NovoRapid® and Fiasp® in Glucose Clamp Study | Biotech Hunter | Biotech Hunter